Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia
Launched by HALLYM UNIVERSITY KANGNAM SACRED HEART HOSPITAL · Jul 6, 2015
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patient who scheduled laparoscopic cholecystectomy under general anesthesia
- • American Society of Anesthesiologist(ASA) class I or II
- • adult patient (age 20 - 65)
- Exclusion Criteria:
- • patient who has liver disease
- • patient who has kidney disease
- • patient who has diabetes mellitus(DM) or heart disease
- • patient who takes opioid or beta-blocker
- • patient who has airway disease
- • patient who has allergy with the drug
About Hallym University Kangnam Sacred Heart Hospital
Hallym University Kangnam Sacred Heart Hospital is a prestigious medical institution located in Seoul, South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a leading sponsor of clinical studies, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to provide high-quality patient care. With a focus on enhancing treatment outcomes and contributing to medical knowledge, Hallym University Kangnam Sacred Heart Hospital collaborates with various stakeholders to ensure the rigorous execution of clinical trials, adhering to the highest ethical and regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials